Welcome to our dedicated page for AMBEV S.A. SEC filings (Ticker: ABEV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMBEV S.A.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMBEV S.A.'s regulatory disclosures and financial reporting.
Ambev S.A., a foreign private issuer, reports that its Board of Directors met on July 29, 2026 in São Paulo, with the minutes recorded in the company’s minute book and certified in extract form.
An exhibit attached to those minutes sets out the composition of the Board of Executive Officers effective September 1st, 2026, with a unified term of office running through December 31st, 2027. The extract is certified by Chairman Michel Dimitrios Doukeris and Secretary Guilherme Malik Parente, and the report is signed by Chief Financial and Investor Relations Officer and Investor Relations Officer Guilherme Fleury de Figueiredo Ferraz Parolari.
Ambev S.A. reported Q2 2026 results with organic total volumes up 1.4% and net revenue up 6.1% year over year. Normalized EBITDA grew 8.9% organically to R$ 6,376.7 million, expanding margin by 80 bps to 31.6%. Normalized profit increased 23.3% to R$ 3,492.7 million, with normalized EPS at R$ 0.22, up 24.2%.
Growth was led by Brazil Beer and Central America & Caribbean, offsetting lower volumes in Brazil NAB, Latin America South and Canada. Operating cash flow rose 54.5% to R$ 4,711.4 million. Ambev returned about R$ 5.9 billion to shareholders year to date and remains in a net cash position of R$ 15,397.4 million. The board set October 6, 2026 for a R$ 1.9 billion Interest on Capital payment and approved a new ~R$ 1.1 billion IOC distribution, while maintaining full-year guidance for Brazil Beer Cash COGS/hl growth between 4.5% and 7.5%.
Ambev S.A. reported consolidated net income of R$7,360,243 for the six months ended June 30, 2026, compared with R$6,595,215 a year earlier, on net sales of R$42,613,399 versus R$42,587,572. Income from operations was R$10,802,646, while basic EPS reached R$0.4584.
Operating cash flow increased to R$7,872,320 from R$4,254,012. Cash and cash equivalents were R$16,610,779 and interest-bearing loans and borrowings totaled R$2,948,960, with total equity of R$88,893,165 and total assets of R$138,209,009 at June 30, 2026.
Ambev continued capital returns, buying back 171,482,300 shares for R$2,751 million under its program and approving interest on capital of R$0.0449 per share (aggregate R$694,639). The company also discloses Brazilian tax proceedings totaling R$113,194,633 classified as possible losses with no provisions.
Ambev S.A. reports management and related persons’ positions in its securities for the period from June 1 to 30, 2026, under Article 11 of CVM Instruction 44/2021. The board of directors group held 30,679,627 common shares and 468,040 common ADRs at both the beginning and end of the month. The management group held 3,298,338 common shares and 19,790 common ADRs, with balances unchanged over the period. The fiscal council group held 2,500 common shares, also unchanged during June 2026.
Ambev S.A. reports its own share transactions for June 2026 under Article 11 of CVM Instruction 44/2021. The company held 247,967,585 common shares in treasury at the beginning of the period and 310,869,798 common shares at the end. Activity included delivery of 97,787 restricted shares at R$16.43 per share and multiple purchases of 3,000,000 common shares on various days through Corretora Santander, with examples including R$16.4202 per share on June 1 and R$16.6634 per share on June 29. All ADR positions are shown as zero throughout.
AMBEV S.A. executive Derbli de Carvalho Joao Coelho Rua filed an initial ownership report showing his equity stake in the company. He directly holds 101,461 common shares. In addition, he has several stock option grants on common shares with exercise prices around $3.41–$4.15 expiring between 2026 and 2029.
The filing also lists multiple restricted share awards that each convert into common shares as they vest, subject to withholding taxes. Footnotes state that different restricted share blocks vest on dates including December 1, 2026, March 1, 2027, December 2, 2027, February 28, 2028, December 1, 2028, and February 16, 2029, outlining a multi‑year vesting schedule.
AMBEV S.A. officer Paulo Andre Zagman reported an open-market sale of 136,250 common shares on May 5, 2026 at an average price of $3.41 per share. After this transaction, he directly holds 230,535 common shares, which include shares represented by American Depositary Shares.
The reported U.S. dollar price reflects a conversion from Brazilian reais using a foreign exchange rate of BRL 4.92 per $1.00 as of the transaction date.
Ambev S.A. filed a Form 6-K presenting its Article 11 CVM Instruction # 44/2021 report for May 2026, detailing transactions in its own securities. The company reports activity only in its treasury common shares and no ADR movements.
The table shows an initial balance of 190,970,849 common shares in treasury and multiple transactions, including deliveries of restricted shares and purchases tied to stock options directly with the company. Ambev also executed repeated market purchases of 3,000,000 common shares per day through Corretora Santander at prices around R$16 per share. The final balance of treasury stock is reported as 247,967,585 common shares, with ADRs remaining at zero.
Ambev S.A. filed a Form 6-K summarizing management and related-party holdings for May 2026 under Brazilian CVM Instruction 44/2021. The board of directors reported no trades and maintained holdings of 30,679,627 common shares and 468,040 ADRs.
The management group reported several transactions, including a sale of 136,250 common shares through XP Corretora at R$16.80000 per share, for a total of R$2,289,000.00. Their common share holdings decreased from 4,753,962 to 3,298,338 shares, while ADR holdings remained 19,790. The fiscal council reported 2,500 common shares with no net change.
Ambev S.A. filed a Form 6-K providing its 2026 registration form information for Brazilian regulators. The filing confirms Ambev remains an operating, publicly held beverage company based in São Paulo, focused on manufacturing and distributing beers, soft drinks and non-alcoholic beverages.
The document restates core corporate data, including its origin in Brazil, active securities registration since 10/30/2013, and listing of shares under ticker ABEV3 on B3. It also identifies Grant Thornton Auditores Independentes Ltda. as independent auditor from 01/01/2024 and Banco Bradesco S.A. as share bookkeeper.
The filing confirms Guilherme Fleury de Figueiredo Ferraz Parolari as Chief Financial and Investor Relations Officer and designated DRI, with a start date of 01/04/2025. It also provides updated contact information and disclosure channels for investor communications.